Viridian Therapeutics, Inc.\DE (VRDN) has 6 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $492K. Most recent filing: Aug. 20, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 20, 2026 filed Aug. 19, 2026 | Tousignant Jennifer Chief Legal Officer | −$103,194 | 34,212 | −4% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 14, 2026 | Tripuraneni Radhika Chief Medical Officer | $528,400 | 80,000 | — | No | |
|
|
||||||
| July 2, 2026 filed July 1, 2026 | Moses Jennifer K. Director | $0 | 32,341 | 0% | No | |
|
|
||||||
| July 2, 2026 filed July 1, 2026 | Gheuens Sarah Director | $0 | 32,341 | 0% | No | |
|
|
||||||
| July 2, 2026 filed July 1, 2026 | Kiselak Tomas Director | $0 | 32,341 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free